plantibody

(redirected from Plantibodies)
Also found in: Dictionary.

plantibody

A type of antibody first produced in tobacco, plantibodies have the advantage of being less immunogenic than mouse antibodies; they have been used in research and have potential therapeutic value.
Mentioned in ?
References in periodicals archive ?
Plantibodies against the plague bacterium and botulism are also in development.
Biolex now has exclusive rights to five United States patents in its Plantibodies portfolio, giving the company coverage for the production of antibodies in transgenic plants and their use to treat humans.
Whaley and Hein are now working to make corn produce the antiherpes plantibodies, as well as antibodies that prevent sperm from reaching an egg.
This is the fourth United States patent granted for Plantibodies technology developed by Epicyte scientists; the company has rights to corresponding granted patents in Japan, Europe and Australia.
To further the cancer-fighting prospects of plantibodies, the researchers now are working with a Scripps immunologist in an attempt to put genes for human-tumor-attacking antibodies into plant cells.
The HIV plantibodies were developed as part of a National Institutes of Health Advanced Technology SBIR award.
These patents will further complement Toxin's intellectual property portfolio by providing specific coverage for a broader range of polymeric substrates and specific sources of antibodies such as plantibodies.
Epicyte owns exclusive rights to this Plantibodies technology and is using it to produce its own pipeline of human monoclonal antibodies.
Epicyte's Plantibodies technology can be used to produce large quantities of pharmaceutical-grade human antibodies and related molecules in plants.
His experience in building critical R&D relationships and acquiring and licensing technologies will be invaluable as Epicyte further develops its infectious disease and sexual health product pipeline and continues to pursue collaborations and licensing opportunities for the Plantibodies technology.
Epicyte, the developer of the Plantibodies technology for manufacturing human monoclonal antibodies in plants, had previously raised $10.
the developer of the Plantibodies technology for manufacturing pharmaceutical-grade human antibodies in plants, today announced that Vincent Gotz has joined the company as vice president of Business Development.